Literature DB >> 12000731

Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer.

Norihiko Tsuchiya1, Yasushi Kondo, Atsushi Takahashi, Hemant Pawar, Junqi Qian, Kazunari Sato, Michael M Lieber, Robert B Jenkins.   

Abstract

We have recently reported that overrepresentation of 8q24 (c-myc) is associated with clinical progression in prostate cancer. In this study, we map the boundaries of the overrepresented region within 8q23-q24 using interphase fluorescent in situ hybridization analysis of paraffin-embedded prostate cancer specimens. One hundred primary prostate cancers and three prostate cancer cell lines were evaluated, and the minimally overrepresented region could be narrowed to the approximately 8.2-Mb region between D8S514 and H47317. This region includes c-myc and is wholly within 8q24. Eukaryotic translation initiation factor 3 subunit 3 does not seem to be overrepresented independent of c-myc in prostate cancer. The cell lines PC3 and DU145 have and do not have 8q24 overrepresentation, respectively. We then selected 39 expressed sequence tags (ESTs) within and surrounding the minimally overrepresented region and performed expression analysis using Northern blot hybridization. Five ESTs/genes including c-myc were overexpressed in both the PC3 cell line and DU145, but the PC3 to DU145 expression ratios were <2. Seven ESTs were overexpressed twofold or more in PC3 compared to DU145. This group included hyaluronan synthase 2, nephroblastoma-overexpressed gene, eukaryotic translation initiation factor 3 subunit 3, and an EST (R69368) encoding a hypothetical protein (BM009). These seven genes as well as c-myc are candidate target genes within the overrepresented 8q24 region and their overexpression may be associated with prostate cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000731      PMCID: PMC1850874          DOI: 10.1016/S0002-9440(10)61126-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Mapping the amplification of EIF3S3 in breast and prostate cancer.

Authors:  N N Nupponen; J Isola; T Visakorpi
Journal:  Genes Chromosomes Cancer       Date:  2000-06       Impact factor: 5.006

2.  Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. Possible roles in RNA binding and macromolecular assembly.

Authors:  K Asano; H P Vornlocher; N J Richter-Cook; W C Merrick; A G Hinnebusch; J W Hershey
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

3.  Detection of amplified genomic sequences in human small-cell lung carcinoma cells by arbitrarily primed-PCR genomic fingerprinting.

Authors:  T Okazaki; J Takita; T Kohno; H Handa; J Yokota
Journal:  Hum Genet       Date:  1996-09       Impact factor: 4.132

4.  Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.

Authors:  P Dubey; H Wu; R E Reiter; O N Witte
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

5.  Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma.

Authors:  B D Li; L Liu; M Dawson; A De Benedetti
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

6.  Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.

Authors:  G Bahrenberg; A Brauers; H G Joost; G Jakse
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

7.  Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells.

Authors:  N Itano; T Sawai; O Miyaishi; K Kimata
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

8.  Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.

Authors:  K Ropponen; M Tammi; J Parkkinen; M Eskelinen; R Tammi; P Lipponen; U Agren; E Alhava; V M Kosma
Journal:  Cancer Res       Date:  1998-01-15       Impact factor: 12.701

9.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.

Authors:  C Collins; J M Rommens; D Kowbel; T Godfrey; M Tanner; S I Hwang; D Polikoff; G Nonet; J Cochran; K Myambo; K E Jay; J Froula; T Cloutier; W L Kuo; P Yaswen; S Dairkee; J Giovanola; G B Hutchinson; J Isola; O P Kallioniemi; M Palazzolo; C Martin; C Ericsson; D Pinkel; D Albertson; W B Li; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Genetic alterations in hormone-refractory recurrent prostate carcinomas.

Authors:  N N Nupponen; L Kakkola; P Koivisto; T Visakorpi
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  12 in total

1.  Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.

Authors:  Melanie A Simpson
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.

Authors:  Claire L Simpson; Cheryl D Cropp; Tiina Wahlfors; Asha George; Marypat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Teuvo Tammela; Johanna Schleutker; Joan E Bailey-Wilson
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

3.  MYC and Prostate Cancer.

Authors:  Cheryl M Koh; Charles J Bieberich; Chi V Dang; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Genes Cancer       Date:  2010-06

Review 4.  Hyaluronan: genetic insights into the complex biology of a simple polysaccharide.

Authors:  John A McDonald; Todd D Camenisch
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

5.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Van Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; William B Isaacs; Jun Luo; Angelo M De Marzo
Journal:  Mod Pathol       Date:  2008-06-20       Impact factor: 7.842

6.  alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.

Authors:  Landon J Inge; Sigrid A Rajasekaran; Daniel Wolle; Sonali P Barwe; Sergey Ryazantsev; Charles M Ewing; William B Isaacs; Ayyappan K Rajasekaran
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

7.  Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.

Authors:  Margaret A Leversha; Jialian Han; Zahra Asgari; Daniel C Danila; Oscar Lin; Rita Gonzalez-Espinoza; Aseem Anand; Hans Lilja; Glenn Heller; Martin Fleisher; Howard I Scher
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

Review 8.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

9.  Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

Authors:  Likun Li; Cheng Hui Ren; Salahaldin A Tahir; Chengzhen Ren; Timothy C Thompson
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy.

Authors:  Tohru Nakagawa; Thomas M Kollmeyer; Bruce W Morlan; S Keith Anderson; Eric J Bergstralh; Brian J Davis; Yan W Asmann; George G Klee; Karla V Ballman; Robert B Jenkins
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.